High satisfaction with fluticasone propionate/salmeterol via diskus reported during experience program in patients with COPD

被引：0
|
作者：
Stoloff, S [1 ]
Samuels, S [1 ]
Braman, S [1 ]
Brown, C [1 ]
Kerney, D [1 ]
Cicale, M [1 ]
机构：
[1] Univ Nevada, Sch Med, Reno, NV 89557 USA
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
10.1378/chest.128.4_MeetingAbstracts.260S-b
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：260S / 260S
页数：1
相关论文
共 50 条
  • [31] Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in them treatment of chronic obstructive pulmonary disease
    Mahler, DA
    Wire, P
    Horstman, D
    Chang, CN
    Yates, J
    Fischer, T
    Shah, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (08) : 1084 - 1091
  • [32] Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
    Soriano, JB
    Vestbo, J
    Pride, NB
    Kiri, V
    Maden, C
    Maier, WC
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) : 819 - 825
  • [33] Reflections on TORCH: Potential Mechanisms for the Survival Benefit of Salmeterol/Fluticasone Propionate in COPD Patients
    Johnson, M.
    Agusti, A. G. N.
    Barnes, N. C.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2008, 5 (06) : 369 - 375
  • [34] Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination
    Brown, Rachel A.
    Allegra, Luigi
    Matera, Maria G.
    Page, Clive P.
    Cazzola, Mario
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (06) : 419 - 424
  • [35] Comparative Assessment Of Umeclidinium Bromide In Combination With Fluticasone Propionate/salmeterol Among Symptomatic COPD Patients
    Huisman, E.
    Van Der Weijden, M.
    Ismaila, A.
    Karabis, A.
    Punekar, Y. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Effect of fluticasone propionate/salmeterol 250/50 on lung hyperinflation and exercise endurance in patients with COPD
    O'Donnell, DE
    Sciurba, F
    Celli, B
    Mahler, DA
    Webb, K
    Kalberg, C
    Crater, C
    Knobil, K
    CHEST, 2005, 128 (04) : 178S - 178S
  • [37] Comparative effectiveness of salmeterol/fluticasone propionate combination 50/500 BID delivered via metered dose inhaler or diskus in patients with reversible airways obstruction
    van Noord, JA
    Lill, H
    Carillo, T
    Davies, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S15 - S15
  • [38] Fluticasone propionate/salmeterol Diskus® combination product provides superior asthma control compared with fluticasone propionate and salmeterol alone in patients previously receiving PRN short-acting beta2-agonists alone
    Rosenthal, RR
    Blake, K
    Strek, M
    Lange, M
    House, KW
    Vandermeer, AK
    Shah, TP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S245 - S245
  • [39] Pharmacokinetics and pharmacodynamics of inhaled advair (fluticasone propionate/salmeterol) diskus and metered-dose inhalers in adult patients with asthma.
    Mehta, Rashmi
    Kathman, Steven
    Andrews, Susan
    Daley-Yates, Peter
    Beerahee, Misba
    Kunka, Robert
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1069 - 1069
  • [40] Efficacy of combination fluticasone furoate/vilanterol (FF/VI) and salmeterol/fluticasone propionate (SFC) over 12 weeks in patients with COPD
    Agusti, Alvar
    De Backer, Wilfried
    de Teresa, Luis
    Zvarich, Michael
    Locantore, Nick
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345